What is the Fiscal Year for Avadel Pharmaceuticals?
Date: November 13, 2026
Avadel Pharmaceuticals's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Dublin
Industry
Biotechnology Research
Stock Symbol
AVDL
Website
https://avadel.comDescription
Avadel is now part of Alkermes! Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex, chronic psychiatric and neurological disorders. We are a global biopharmaceutical company headquartered in Dublin, Ireland, with U.S. locations in Massachusetts and Ohio. Alkermes seeks to make a meaningful difference in the way people living with addiction, serious mental illness and sleep disorders manage their disease. For more information about Alkermes, please visit us at www.alkermes.com. Follow Alkermes on LinkedIn for future updates. See our Community Guidelines: https://www.alkermes.com/social-community-guidelines
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Avadel Pharmaceuticals and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.